人群免疫与疾病传播的整合血清学监测
本文为观点文章,提出利用多重抗体检测对现有血清学调查进行更广泛检测,以实现整合监测。文章指出整合监测在公共卫生价值上可能优于当前按单一疾病垂直监测的趋势,并描述了实验室与数据科学的创新及标本采集、检测和分析方面的剩余挑战。
要点
- 抗体可识别疫苗可预防疾病的保护性免疫及既往暴露。
- 多重抗体检测可拓展现有血清学调查,创造整合监测机会。
- 整合监测平台可帮助更快更精准识别全球卫生规划差距。
核心结论
- 整合血清学监测可创造新机会,更快速精准地识别从疫苗接种不足到新发病原体及多层健康差异的全球卫生规划差距。
研究设计与样本
- 本文为观点文章,论述利用多重抗体检测对现有血清学调查进行更广泛检测以开展整合监测。
主要发现
- 抗体是唯一能同时识别保护性免疫和测量既往暴露于多种病原体的生物标志物。
- 当前多数传染病监测维持单一疾病重点,而多重抗体检测现有血清学调查可创造整合监测新机会。
- 整合监测在多个领域可能比当前通过垂直项目独立监测疾病的趋势为公共卫生工作增加更多价值。
- 实验室和数据科学的创新应加速整合,并识别了标本采集、检测和分析方面的剩余挑战。
局限性
- 原文提及在标本采集、检测和分析方面仍存在挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antibodies are unique among biomarkers in their ability to identify persons with protective immunity to vaccine-preventable diseases and to measure past exposure to diverse pathogens. Most infectious disease surveillance maintains a single-disease focus, but broader testing of existing serologic surveys with multiplex antibody assays would create new opportunities for integrated surveillance. In this perspective, we highlight multiple areas for potential synergy where integrated surveillance could add more value to public health efforts than the current trend of independent disease monitoring through vertical programs. We describe innovations in laboratory and data science that should accelerate integration and identify remaining challenges with respect to specimen collection, testing, and analysis. Throughout, we illustrate how information generated through integrated surveillance platforms can create new opportunities to more quickly and precisely identify global health program gaps that range from undervaccination to emerging pathogens to multilayered health disparities that span diverse communicable diseases.
引用
- Arnold BF, Scobie HM, Priest JW, et al. Integrated Serologic Surveillance of Population Immunity and Disease Transmission. Emerg Infect Dis. 2018. PMID: 29912680. doi:10.3201/eid2407.171928
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。